{"organizations": [], "uuid": "6900ada2db27b76c0c5593504f4e95f58079244e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ionis-pharmaceuticals-reports-q4-e/brief-ionis-pharmaceuticals-reports-q4-earnings-per-share-of-0-02-idUSASB0C7O5", "country": "US", "domain_rank": 408, "title": "BRIEF-Ionis Pharmaceuticals Reports Q4 Earnings Per Share of $0.02‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.976, "site_type": "news", "published": "2018-02-27T20:14:00.000+02:00", "replies_count": 0, "uuid": "6900ada2db27b76c0c5593504f4e95f58079244e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ionis-pharmaceuticals-reports-q4-e/brief-ionis-pharmaceuticals-reports-q4-earnings-per-share-of-0-02-idUSASB0C7O5", "ord_in_thread": 0, "title": "BRIEF-Ionis Pharmaceuticals Reports Q4 Earnings Per Share of $0.02‍​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - ionis pharmaceuticals inc", "sentiment": "neutral"}, {"name": "dec", "sentiment": "none"}, {"name": "ionis pharmaceuticals", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Ionis Pharmaceuticals Inc:\n* IONIS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 REVENUE $172.3 MILLION * Q4 EARNINGS PER SHARE $0.02‍​ * Q4 EARNINGS PER SHARE VIEW $0.01, REVENUE VIEW $124.7 MILLION -- THOMSON REUTERS I/B/E/S\n* IONIS PHARMACEUTICALS-‍AS OF DEC 31, 2017, HAD CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS OF MORE THAN $1 BILLION COMPARED TO $665 MILLION AT DEC 31, 2016​\n* IONIS PHARMACEUTICALS - ‍CASH BALANCE AT DEC 31, 2017 INCLUDED PROCEEDS FROM AKCEA‘S 2017 IPO AND NOVARTIS’ INVESTMENT IN AKCEA​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T20:14:00.000+02:00", "crawled": "2018-02-28T12:53:28.004+02:00", "highlightTitle": ""}